Ferrous bisglycinate improves hemoglobin levels and reduces side effects in pregnant women

Fischer JA, Cherian AM, Bone JN, Karakochuk CD.

Ferrous bisglycinate improves hemoglobin levels and reduces side effects in pregnant women

24 Apr 2025

This systematic review and meta-analysis evaluated the efficacy and tolerability of ferrous bisglycinate, an amino acid chelated form of iron, compared to traditional iron supplements in various populations, including pregnant women.

The analysis included 17 randomized controlled trials, with nine focusing on pregnant women. Findings indicated that ferrous bisglycinate supplementation led to a significant increase in hemoglobin concentrations compared to other iron supplements. Additionally, it was associated with a 64% reduction in gastrointestinal adverse events, such as nausea and constipation.

These results suggest that ferrous bisglycinate is both more effective and better tolerated than conventional iron supplements during pregnancy. Its improved bioavailability allows for lower dosing, potentially enhancing compliance among pregnant women.

The effects of oral ferrous bisglycinate supplementation on hemoglobin and ferritin concentrations in adults and children: a systematic review and meta-analysis of randomised controlled trials
Fischer JA, Cherian AM, Bone JN, Karakochuk CD. Nutr Rev. 2023 Jul 10;81(8):904-920.

https://pubmed.ncbi.nlm.nih.gov/36728680/

Spread the word
Iron Maternal Health NurtureMulti Research
Back to blog